You have 9 free searches left this month | for more free features.

midostaurin

Showing 1 - 25 of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML, Adult Trial in Berne (HDM201, Midostaurin)

Terminated
  • AML, Adult
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Oct 3, 2022

FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

Available
  • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
  • midostaurin
  • (no location specified)
Oct 18, 2022

Core Binding Factor Acute Myeloid Leukemia (CBF-AML) Trial in Milano (Midostaurin)

Recruiting
  • Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
  • Midostaurin
  • Milano, Italy
    Ospedale Cà Granda - Niguarda S.C: Ematologia
Jan 22, 2022

Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

Recruiting
  • Acute Myeloid Leukemia
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022

Healthcare Resource Utilization in Adults Diagnosed With Acute

Completed
  • Acute Myeloid Leukemia (AML)
  • Midostaurin
  • Helsinki, Finland
    Novartis Investigative Site
Aug 3, 2022

Acute Myeloid Leukemia, Adult Trial in Germany (Midostaurin)

Terminated
  • Acute Myeloid Leukemia, Adult
  • Midostaurin
  • Chemnitz, Germany
  • +3 more
Jan 20, 2022

Acute Myeloid Leukemia Trial in Worldwide (Midostaurin, Placebo)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Midostaurin
  • Placebo
  • Hong Kong, Hong Kong
  • +40 more
Jan 20, 2023

Hepatic Impairment Trial in Worldwide (Midostaurin)

Completed
  • Hepatic Impairment
  • Midostaurin
  • San Antonio, Texas
  • +6 more
May 8, 2021

AML/MDS Trial in Worldwide (Decitabine, Midostaurin)

Active, not recruiting
  • AML/MDS
  • Antwerpen, Belgium
  • +36 more
Dec 29, 2021

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +9 more
Jan 3, 2023

Acute Myeloid Leukemia Trial in Worldwide (Midostaurin)

Completed
  • Acute Myeloid Leukemia
  • Midostaurin
  • Pleven, Bulgaria
  • +85 more
Feb 11, 2022

Acute Myeloid Leukemia (AML) Trial in Worldwide (Midostaurin, Midostaurin Placebo, Chemotherapy)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Midostaurin
  • +2 more
  • Chicago, Illinois
  • +132 more
Jan 24, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

Suspended
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Adelaide, Australia
  • +193 more
Jan 5, 2023

Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)

Completed
  • Acute Myeloid Leukemia
  • Midostaurin
  • Standard of Care
  • La Jolla, California
  • +18 more
Mar 12, 2021

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Italy (Cytarabine, Daunorubicin, Midostaurin)

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Bari, Italy
  • +19 more
Mar 1, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Anchorage, Alaska
  • +506 more
Jan 28, 2023

Newly Diagnosed FLT3 Mutated AML Trial in United States (Crenolanib, Midostaurin, Cytarabine)

Recruiting
  • Newly Diagnosed FLT3 Mutated AML
  • Duarte, California
  • +30 more
May 21, 2020

Acute Myeloid Leukemia (AML) Trial in Germany, United States (cytarabine, daunorubicin HCl, midostaurin)

Completed
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +5 more
Dec 16, 2020

FLT3-mutated Acute Myeloid Leukemia Trial in Hamilton, Montreal (Midostaurin)

No longer available
  • FLT3-mutated Acute Myeloid Leukemia
  • Midostaurin
  • Hamilton, Ontario, Canada
  • +1 more
Oct 14, 2019

Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Trial in

No longer available
  • Acute Myeloid Leukemia (AML) With
  • FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
  • Midostaurin
  • Phoenix, Arizona
  • +43 more
Jul 14, 2020

Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, FLT3 Tyrosine Kinase Domain Point

Terminated
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 17, 2019

Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)

Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +175 more
Aug 16, 2021

Acute Myeloid Leukemia Trial in Austria, Germany (Midostaurin, Cytarabine, Daunorubicin)

Completed
  • Acute Myeloid Leukemia
  • Midostaurin
  • +2 more
  • Innsbruck, Austria
  • +54 more
Jun 3, 2020